CSF2 and cancer: In these cancers, the G-/GM-CSF(R) promote progression possibly using auto-/paracrine activation of antiapoptotic and pro-angiogenic pathways via activation of STAT-3 transcription factor or an increased expression of VEGF/VEGFR 37–41.